ATE85893T1 - Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis. - Google Patents

Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.

Info

Publication number
ATE85893T1
ATE85893T1 AT87115790T AT87115790T ATE85893T1 AT E85893 T1 ATE85893 T1 AT E85893T1 AT 87115790 T AT87115790 T AT 87115790T AT 87115790 T AT87115790 T AT 87115790T AT E85893 T1 ATE85893 T1 AT E85893T1
Authority
AT
Austria
Prior art keywords
somatostatin
rheumatoid arthritis
medication
manufacture
treatment
Prior art date
Application number
AT87115790T
Other languages
English (en)
Inventor
Marco Matucci Cerinic
Simone Marabini
Original Assignee
Serono Ind Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Ind Farma filed Critical Serono Ind Farma
Application granted granted Critical
Publication of ATE85893T1 publication Critical patent/ATE85893T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/31Somatostatins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT87115790T 1986-11-04 1987-10-27 Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis. ATE85893T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8648617A IT1208760B (it) 1986-11-04 1986-11-04 Trattamento delle malattie infiammatorie articolari
EP87115790A EP0266665B1 (de) 1986-11-04 1987-10-27 Verwendung von Somatostatin zur Herstellung eines Arzneimittels für die Behandlung von rheumatoider Arthritis

Publications (1)

Publication Number Publication Date
ATE85893T1 true ATE85893T1 (de) 1993-03-15

Family

ID=11267657

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87115790T ATE85893T1 (de) 1986-11-04 1987-10-27 Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.

Country Status (11)

Country Link
US (1) US4966889A (de)
EP (1) EP0266665B1 (de)
JP (1) JPH0725693B2 (de)
AT (1) ATE85893T1 (de)
DE (1) DE3784308T2 (de)
ES (1) ES2053499T3 (de)
GR (1) GR3007141T3 (de)
HK (1) HK139796A (de)
IL (1) IL84327A (de)
IT (1) IT1208760B (de)
MX (1) MX9203339A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
US6645485B2 (en) * 2000-05-10 2003-11-11 Allan R. Dunn Method of treating inflammation in the joints of a body
CA2647986C (en) * 2006-03-31 2014-07-08 Erasmus University Medical Center Rotterdam Compositions for tumor growth control
JP7010934B2 (ja) * 2016-06-10 2022-02-10 レギュラキス 変形性関節症の治療のためのペプチド

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748153A (en) * 1985-04-29 1988-05-31 Merck & Co., Inc. Compounds having somatostatin-like activity useful as local anti-inflammatory agents
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents

Also Published As

Publication number Publication date
IL84327A0 (en) 1988-04-29
EP0266665B1 (de) 1993-02-24
EP0266665A3 (en) 1989-10-25
DE3784308D1 (de) 1993-04-01
GR3007141T3 (de) 1993-07-30
IT1208760B (it) 1989-07-10
DE3784308T2 (de) 1993-07-08
EP0266665A2 (de) 1988-05-11
JPH0725693B2 (ja) 1995-03-22
MX9203339A (es) 1992-08-31
IL84327A (en) 1991-09-16
HK139796A (en) 1996-08-02
US4966889A (en) 1990-10-30
IT8648617A0 (it) 1986-11-04
ES2053499T3 (es) 1994-08-01
JPS63179832A (ja) 1988-07-23

Similar Documents

Publication Publication Date Title
FI905956A0 (fi) Foerfarande foer producering av ett biologiskt aktivt protein.
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
ATE75483T1 (de) Oligonukleotides heilmittel und dessen herstellungsverfahren.
DE69333607D1 (de) Vorrichtung zur Herstellung von vorgefüllten, sterilen Abgabevorrichtungen
DE59008005D1 (de) Verfahren zur Herstellung von hochmolekularen Copolyarylensulfiden.
ATE22532T1 (de) Pharmazeutische zusammensetzung.
ATE85893T1 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
DE58901037D1 (de) Vorrichtung zur herstellung von klareisstuecken.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DE3860105D1 (de) Verfahren zur herstellung von 4,4'-dichlordiphenylsulfonen.
DE68919593D1 (de) Verwendung von Zofenopril zur Herstellung von Medikamenten gegen rheumatoide Arthritis.
DE59007022D1 (de) Verfahren zur kontinuierlichen Herstellung von Nylon 4,6.
DE3888697D1 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
DE68915122D1 (de) Verfahren zur Herstellung von Backhefe.
DE3862402D1 (de) Verfahren zur herstellung von 2,3,5,6-tetrafluorbenzoesaeure.
ATE97678T1 (de) Verfahren zur herstellung von copolyarylensulfiden.
ATE100838T1 (de) Verfahren zur herstellung von copolyarylensulfiden.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time